Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

1.

Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.

Zhang J, Lambert-Messerlian G, Palomaki GE, Canick JA.

Prenat Diagn. 2011 Jun;31(6):583-8. doi: 10.1002/pd.2755. Epub 2011 Apr 11.

PMID:
21480302
[PubMed - indexed for MEDLINE]
2.

Obstetrical complications associated with abnormal maternal serum markers analytes.

Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, Wyatt P; Society of Obstetricians and Gynaecologists of Canada Genetics Committee.

J Obstet Gynaecol Can. 2008 Oct;30(10):918-49. Review. English, French.

PMID:
19038077
[PubMed - indexed for MEDLINE]
3.
4.

First- and second-trimester screening: detection of aneuploidies other than Down syndrome.

Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.

Obstet Gynecol. 2007 Sep;110(3):651-7.

PMID:
17766613
[PubMed - indexed for MEDLINE]
5.

Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.

Crossley JA, Aitken DA, Waugh SM, Kelly T, Connor JM.

Prenat Diagn. 2002 Mar;22(3):247-55.

PMID:
11920904
[PubMed - indexed for MEDLINE]
6.

Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.

Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK.

Prenat Diagn. 2002 Oct;22(10):893-7.

PMID:
12378572
[PubMed - indexed for MEDLINE]
7.

Second trimester two-step trisomy 18 screening using maternal serum markers.

Muller F, Sault C, Lemay C, Roussel-Mizon N, Forestier F, Frendo JL; ABA Collaborative Group.

Prenat Diagn. 2002 Jul;22(7):605-8.

PMID:
12124697
[PubMed - indexed for MEDLINE]
8.

Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy.

Spencer K.

Prenat Diagn. 2002 Dec;22(13):1229-32.

PMID:
12478639
[PubMed - indexed for MEDLINE]
9.

The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.

Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K.

Ann Clin Biochem. 2003 May;40(Pt 3):219-31.

PMID:
12803832
[PubMed - indexed for MEDLINE]
10.

SURUSS in perspective.

Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A.

Semin Perinatol. 2005 Aug;29(4):225-35.

PMID:
16104673
[PubMed - indexed for MEDLINE]
11.

Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.

Krantz DA, Hallahan TW, Macri VJ, Macri JN.

Prenat Diagn. 2005 Aug;25(8):635-40.

PMID:
16049986
[PubMed - indexed for MEDLINE]
12.

ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.

Spencer K, Cowans NJ.

J Matern Fetal Neonatal Med. 2007 Sep;20(9):645-50.

PMID:
17701664
[PubMed - indexed for MEDLINE]
13.

Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy.

Miron P, Côté YP, Lambert J.

Prenat Diagn. 2008 Mar;28(3):180-5. doi: 10.1002/pd.1930.

PMID:
18264956
[PubMed - indexed for MEDLINE]
14.

Appropriate biochemical parameters in first-trimester screening for Down syndrome.

Cuckle HS, van Lith JM.

Prenat Diagn. 1999 Jun;19(6):505-12.

PMID:
10416963
[PubMed - indexed for MEDLINE]
15.

First-trimester or second-trimester screening, or both, for Down's syndrome.

Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium.

N Engl J Med. 2005 Nov 10;353(19):2001-11.

PMID:
16282175
[PubMed - indexed for MEDLINE]
Free Article
16.

Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18.

Spencer K, Crossley JA, Green K, Worthington DJ, Brownbill K, Aitken DA.

Prenat Diagn. 1999 Dec;19(12):1127-34.

PMID:
10590430
[PubMed - indexed for MEDLINE]
17.

Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.

Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH.

Ultrasound Obstet Gynecol. 2008 Jun;31(6):618-24. doi: 10.1002/uog.5331.

PMID:
18461550
[PubMed - indexed for MEDLINE]
Free Article
18.

SURUSS in perspective.

Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A.

BJOG. 2004 Jun;111(6):521-31.

PMID:
15198778
[PubMed - indexed for MEDLINE]
19.

First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.

Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH.

Ultrasound Obstet Gynecol. 2008 May;31(5):493-502. doi: 10.1002/uog.5332.

PMID:
18432600
[PubMed - indexed for MEDLINE]
Free Article
20.

Triploidy identified through second-trimester serum screening.

Huang T, Alberman E, Wald N, Summers AM.

Prenat Diagn. 2005 Mar;25(3):229-33.

PMID:
15791661
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk